|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing bank deposits | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Time deposits with other financial institutions | ||||||||||||||||||||
| Securities available for sale | ||||||||||||||||||||
| Federal Home Loan Bank stock (FHLB) | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans, net of unearned income | ||||||||||||||||||||
| Allowance for credit losses on loans | ||||||||||||||||||||
| Total loans, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Interest Receivable | ||||||||||||||||||||
| Bank-owned life insurance (BOLI) | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Demand and NOW checking | ||||||||||||||||||||
| Money market | ||||||||||||||||||||
| Savings | ||||||||||||||||||||
| Time deposits over $250,000 | ||||||||||||||||||||
| Other time deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Escrow deposits | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Treasury Stock, at cost | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Unallocated common shares held by ESOP | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
| Par value (in dollars per share) | ||||||||||||||||||||
| Shares authorized (in shares) | ||||||||||||||||||||
| Shares issued (in shares) | ||||||||||||||||||||
| Shares outstanding (in shares) | ||||||||||||||||||||
| Treasury shares (in shares) |
Loading...
